Rare diseases
Investigational molecules
Locations
Back to Germany1 786 clinical trials in Berlin, Germany across 17 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)A study to evaluate the effectiveness and safety of LAD603 in adults with severe to very severe alopecia areata
GermanyA study to evaluate the effectiveness and safety of lebrikizumab in adults with nummular eczema who do not respond well to topical corticosteroids.
GermanyA Phase III Study of Survodutide in Adults with Compensated NASH Cirrhosis to Assess Liver Outcomes and Safety
GermanyA Phase III trial of BI 456906 weekly injections in adults with NASH and stage 2‑3 liver fibrosis
GermanyA study to evaluate the effects of BI 764198 in adults and adolescents with focal segmental glomerulosclerosis (FSGS)
GermanyA study to evaluate the long-term safety and effectiveness of barzolvolimab in patients with chronic spontaneous urticaria
GermanyStudy of sotorasib, panitumumab and a drug combination for patients with metastatic colorectal cancer with KRAS p.G12C mutation.
GermanyStudy to evaluate the long-term safety and effectiveness of lunsekimig in adults with moderate to severe asthma
GermanyStudy of BNT327 and a drug combination for patients with untreated metastatic or locally recurrent triple-negative breast cancer
GermanyA study to evaluate the effectiveness and safety of ritlecitinib tosilate and loratadine in adults with chronic spontaneous urticaria (hives)
GermanyA study to evaluate the effectiveness and safety of duvakitug in patients with moderate to severe Crohn's disease
GermanyA study to evaluate the efficacy and safety of duvakitug in patients with moderate to severe Crohn's disease
GermanyThe busiest research cities in the country
What the registry says about research in the country
Advanced clinical trials focusing on various cancer treatments, including studies of metastatic prostate cancer, colorectal cancer, and innovative approaches for breast cancer treatment.
Novel combination therapies and targeted treatments are being evaluated to improve patient outcomes across multiple cancer types.
Comprehensive vaccine development programs targeting various viral infections, including studies on respiratory syncytial virus, cytomegalovirus, and herpes zoster.
These trials aim to enhance immune response and provide long-term protection against serious viral infections.
Innovative treatments for various chronic conditions, including autoimmune dementia, hypertriglyceridemia, and studies in transplant medicine.
Research focuses on developing targeted therapies and improving treatment outcomes for long-term conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
